Valued Wealth Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.8K Buy
118
+17
+17% +$1.49K ﹤0.01% 295
2026
Q1
$8.64K Buy
101
+24
+31% +$2.14K ﹤0.01% 316
2025
Q4
$6.1K Buy
77
+11
+17% +$862 ﹤0.01% 277
2025
Q3
$5.26K Sell
66
-15
-19% -$1.28K ﹤0.01% 281
2025
Q2
$7.36K Sell
81
-24
-23% -$2.19K ﹤0.01% 242
2025
Q1
$9.88K Sell
105
-2
-2% -$179 0.01% 229
2024
Q4
$9.73K Sell
107
-20
-16% -$1.91K 0.01% 235
2024
Q3
$13.2K Buy
127
+38
+43% +$3.87K 0.01% 187
2024
Q2
$8.64K Buy
89
+37
+71% +$3.41K 0.01% 215
2024
Q1
$4.68K Buy
52
+17
+49% +$1.44K ﹤0.01% 255
2023
Q4
$2.49K Buy
+35
New +$2.63K ﹤0.01% 276

Other funds holding CL

Valued Wealth Advisors's CL Position: Q2 2026 in Review

Valued Wealth Advisors increased its Colgate-Palmolive (CL) stake by 17% in Q2 2026, buying an estimated $1.49K and bringing the position to 118 shares worth $10.8K. The position accounts for ﹤0.01% of the portfolio, ranked #295.

Valued Wealth Advisors first reported a position in CL in Q4 2023 and has held it in 11 quarters since. The position peaked at $13.2K in Q3 2024. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Valued Wealth Advisors held 118 shares of Colgate-Palmolive worth $10.8K as of Q2 2026.
  • Valued Wealth Advisors bought 17 Colgate-Palmolive shares in Q2 2026, an estimated $1.49K.
  • Colgate-Palmolive made up ﹤0.01% of Valued Wealth Advisors's portfolio in Q2 2026, its #295 holding.
  • Valued Wealth Advisors first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 11 quarters since.
  • Valued Wealth Advisors's Colgate-Palmolive position peaked at $13.2K in Q3 2024.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Valued Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.